drugset / Trial / NCT00502346

A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers

NCT00502346 ↗

Phase 1 Completed 342 enrolled Prism Pharmaceuticals
RandomizedParallel-groupDouble-blind

Summary

The primary objective of the study is to compare the effect of PM101 I.V. administered as an immediate intravenous bolus versus placebo on systolic blood pressure. Secondary objectives include evaluation of change from baseline in heart rate and change from baseline to the lowest value in mean arterial pressure and diastolic pressure.

Timeline

Start
2007-07-03
Primary completion
2007-11-02
Completion
2007-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PM10 Unknown — Intravenous

Indications

No indication recorded.